| Overview |
| bs-15216R-PE-Cy3 |
| C6orf129 Polyclonal Antibody, PE-Cy3 Conjugated |
| WB |
| Human, Mouse, Rat, Cow, Sheep, Pig |
| Specifications |
| PE-Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human C6orf129 |
| 1-50/97 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 154467 |
| Cell membrane |
| CCDC167; C6orf129; CCDC167; CC167_HUMAN; Chromosome 6 open reading frame 129; Coiled coil domain containing 167; HSPC265; RP1-153P14.2; Transmembrane and coiled-coil domain-containing protein C6orf129. |
| C6orf129 is a Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf129 gene product has been provisionally designated C6orf129 pending further characterization. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz